<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03406325</url>
  </required_header>
  <id_info>
    <org_study_id>REC-2017-17</org_study_id>
    <nct_id>NCT03406325</nct_id>
  </id_info>
  <brief_title>Mast Cell Activation Test in Allergic Disease</brief_title>
  <official_title>Assessment of Mast Cell Activation Diagnostic Test in Patients With Allergic Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hong Kong Sanatorium &amp; Hospital</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hong Kong Sanatorium &amp; Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Activation of mast cells in the immune system is known to cause allergic reactions sometimes
      with severe systemic symptoms. The investigators have recently developed a blood-based mast
      cell activation diagnostic test in which levels of functional activation in-vitro in primary
      cultured mast cells generated from the peripheral blood of single individuals can be
      assessed. It is the hypothesis that the test can be used to predict the potential state of
      in-vivo mast cell activation in any individual based on the functional activation profiles
      exhibited by their cultured mast cells. The investigators now wish to translate their
      in-vitro findings in a pilot study to disease groups where mast cell activation is expected
      to be high. These include highly allergic individuals; those with chronic idiopathic
      urticaria; those with mastocytosis; and those with the mast cell activation syndrome.
      Furthermore, they will use the functional genomics approach to identify gene expression
      biomarkers that are correlated with such diseases. The results will be compared with data
      that have been collected from a cohort of healthy control blood donors.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to assess whether patients with severe allergic diseases
      exhibit high levels of mast cell activation as determined by the mast cell activation
      diagnostic test the investigators have developed. They anticipate that patients with history
      of severe allergic reactions will show up as high responders in the blood-based mast cell
      activation diagnostic test. Moreover, using microarray analysis as the approach for gene
      expression studies, they anticipate further that genomics biomarkers that are correlated with
      the high functional activation of the in-vitro mast cells derived from these patients can be
      readily identified.

      About 100 ml of peripheral venous blood from individual patients will be drawn into
      heparinized syringes and collected in a blood-collecting bag/tube containing silica. The
      bag/tube will be promptly processed for the generation of primary human mast cell cultures
      using the protocol that has previously been developed [Inflammation Research 66: 25 (2017).
      After culturing for 9 weeks, the resulting human mast cells will be analyzed for both their
      functional activity in terms of histamine release in response to the activation of
      high-affinity Immunoglobulin E (IgE) receptors in these cells and their gene expression
      profiles using microarray analysis. The in-vitro functional and genomics data will be
      correlated with specific diagnoses and measurements of blood prostaglandin D2 (PGD2), PGD2
      metabolites, tryptase and histamine levels in blood. For mediator assays, plasma from each
      subject will be collected after the cluster of differentiation 34 positive (CD34+) isolation
      step and the samples will be aliquoted and frozen at -80 degrees centigrade for subsequent
      analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Actual">December 1, 2019</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mast Cell Activation Test Results for Validation Group</measure>
    <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
    <description>Mast Cell Activation Test results of high/low level of house dust mite sensitivity by using normal donor cultured mast cells for validation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluation of Patient's Serum for Autoreactivity on Normal Average Responder Mast Cell Activation</measure>
    <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
    <description>Patient's serum was incubated with mast cells derived from normal donors for detection of mast cell activation as evidenced by histamine release.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage Histamine Release by Normal Average Responder Mast Cells + Patient's Serum to Assess Autoreactivity</measure>
    <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
    <description>percentage of total histamine release by normal average responder mast cells that had been activated with patient's serum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage Histamine Release by Patient's Mast Cells + Immunoglobulin E (IgE)/Anti-IgE</measure>
    <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
    <description>percentage of total histamine release by patient's mast cells that had been activated with anti-IgE</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Histamine Release by Patient's Mast Cells + Patient's Serum + Allergen</measure>
    <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
    <description>Percentage of total histamine release when patient's mast cells were activated with patient's own serum and Der p2. Each patient's results are reported individually.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cell Yield Per 100ml Blood</measure>
    <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
    <description>Cell yield of patient's mast cell culture after 9 weeks in culture as an index of cell growth and differentiation.</description>
  </primary_outcome>
  <number_of_groups>7</number_of_groups>
  <enrollment type="Actual">19</enrollment>
  <condition>Asthma</condition>
  <condition>Mastocytosis</condition>
  <condition>Mast Cell Activation Syndrome</condition>
  <condition>Food Allergy</condition>
  <condition>Chronic Idiopathic Urticaria</condition>
  <condition>Anaphylaxis</condition>
  <condition>Eczema</condition>
  <arm_group>
    <arm_group_label>urticaria</arm_group_label>
    <description>Patients with this condition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>asthma</arm_group_label>
    <description>Patients with this condition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>eczema</arm_group_label>
    <description>Patients with this condition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>food allergy</arm_group_label>
    <description>Patients with this condition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>anaphylaxis</arm_group_label>
    <description>Patients with this condition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mastocytosis</arm_group_label>
    <description>Patients with this condition</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mast cell activating syndrome</arm_group_label>
    <description>Patients with this condition</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples for mediator measurements
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Highly allergic individuals
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Any patients with the above diagnoses -

        Exclusion Criteria:

        Children &lt; 18 years old; those who are unwilling or unable to donate blood; pregnant
        mothers.

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tak H Lee</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hong Kong Sanatorium and Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hong Kong Sanatorium &amp; Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <reference>
    <citation>Tam IYS, Ng CW, Tam SY, Lau HYA. Novel six-week protocol for generating functional human connective tissue-type (MC(TC)) mast cells from buffy coats. Inflamm Res. 2017 Jan;66(1):25-37. doi: 10.1007/s00011-016-0989-z. Epub 2016 Sep 15. Erratum in: Inflamm Res. 2017 Nov 13;:.</citation>
    <PMID>27628164</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 14, 2018</study_first_submitted>
  <study_first_submitted_qc>January 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <results_first_submitted>February 10, 2020</results_first_submitted>
  <results_first_submitted_qc>March 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">April 9, 2020</results_first_posted>
  <last_update_submitted>March 27, 2020</last_update_submitted>
  <last_update_submitted_qc>March 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hong Kong Sanatorium &amp; Hospital</investigator_affiliation>
    <investigator_full_name>Lee Tak Hong</investigator_full_name>
    <investigator_title>Director Allergy Centre</investigator_title>
  </responsible_party>
  <keyword>mast cell</keyword>
  <keyword>allergy</keyword>
  <keyword>genomic</keyword>
  <keyword>biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mastocytosis</mesh_term>
    <mesh_term>Urticaria</mesh_term>
    <mesh_term>Food Hypersensitivity</mesh_term>
    <mesh_term>Anaphylaxis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 21, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT03406325/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 1, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/25/NCT03406325/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>19 patients were recruited in the study. 12 were used for validation. 7 were used for patient-specific testing. Therefore, there were 1 validation group and 7 individuals' result.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Validation Group</title>
          <description>Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples</description>
        </group>
        <group group_id="P2">
          <title>SH#1</title>
          <description>Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema</description>
        </group>
        <group group_id="P3">
          <title>SH#2</title>
          <description>Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema</description>
        </group>
        <group group_id="P4">
          <title>SH#3</title>
          <description>Female patient, Total IgE: 5333KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema</description>
        </group>
        <group group_id="P5">
          <title>SH#4</title>
          <description>Male patient, Total IgE: 4070KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema, Urticaria</description>
        </group>
        <group group_id="P6">
          <title>SH#5</title>
          <description>Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis</description>
        </group>
        <group group_id="P7">
          <title>SH#6</title>
          <description>Female patient, Total IgE: 13KU/L; Der p2IgE: &lt;0.1KU/L; clinical diagnosis: Mast cell activation syndrome</description>
        </group>
        <group group_id="P8">
          <title>SH#7</title>
          <description>Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>During recruitment period, no participants with asthma, food allergy, mastocytosis were recruited.</population>
      <group_list>
        <group group_id="B1">
          <title>Validation Group</title>
          <description>Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples</description>
        </group>
        <group group_id="B2">
          <title>SH#1</title>
          <description>Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema</description>
        </group>
        <group group_id="B3">
          <title>SH#2</title>
          <description>Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema</description>
        </group>
        <group group_id="B4">
          <title>SH#3</title>
          <description>Female patient, Total IgE: 5333KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema</description>
        </group>
        <group group_id="B5">
          <title>SH#4</title>
          <description>Male patient, Total IgE: 4070KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema, Urticaria</description>
        </group>
        <group group_id="B6">
          <title>SH#5</title>
          <description>Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis</description>
        </group>
        <group group_id="B7">
          <title>SH#6</title>
          <description>Female patient, Total IgE: 13KU/L; Der p2IgE: &lt;0.1KU/L; clinical diagnosis: Mast cell activation syndrome</description>
        </group>
        <group group_id="B8">
          <title>SH#7</title>
          <description>Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria</description>
        </group>
        <group group_id="B9">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="1"/>
            <count group_id="B3" value="1"/>
            <count group_id="B4" value="1"/>
            <count group_id="B5" value="1"/>
            <count group_id="B6" value="1"/>
            <count group_id="B7" value="1"/>
            <count group_id="B8" value="1"/>
            <count group_id="B9" value="19"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hong Kong</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinical diagnosis</title>
          <description>Clinical diagnosis of participants before Mast cell activation test</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Eczema</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Rhinitis</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Urticaria</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Exercise-induced anaphylaxis</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="1"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Mast cell activation syndrome</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Eczema and Urticaria</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mast Cell Activation Test Results for Validation Group</title>
        <description>Mast Cell Activation Test results of high/low level of house dust mite sensitivity by using normal donor cultured mast cells for validation.</description>
        <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
        <population>Mast cells were cultured from blood of normal donors to validate the (Mast Cell Activation) MAT assay. The serum samples were obtained from allergic patients with sensitivities to Der p2 and used for passive sensitization of normal donor mast cells followed by their activation by Der p2 allergen. Data were collected only from the validation group.</population>
        <group_list>
          <group group_id="O1">
            <title>Validation Group</title>
            <description>Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples</description>
          </group>
        </group_list>
        <measure>
          <title>Mast Cell Activation Test Results for Validation Group</title>
          <description>Mast Cell Activation Test results of high/low level of house dust mite sensitivity by using normal donor cultured mast cells for validation.</description>
          <population>Mast cells were cultured from blood of normal donors to validate the (Mast Cell Activation) MAT assay. The serum samples were obtained from allergic patients with sensitivities to Der p2 and used for passive sensitization of normal donor mast cells followed by their activation by Der p2 allergen. Data were collected only from the validation group.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>High level of house dust mite sensitivity</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>MAT positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>MAT negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Low level of house dust mite sensitivity</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>MAT positive</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>MAT negative</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Evaluation of Patient's Serum for Autoreactivity on Normal Average Responder Mast Cell Activation</title>
        <description>Patient's serum was incubated with mast cells derived from normal donors for detection of mast cell activation as evidenced by histamine release.</description>
        <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
        <population>Serum samples were obtained from 19 patients in total, of whom 12 were in the validation group. The other 7 patients were studied more extensively in the trial and their data is reported individually in this section and thereafter.</population>
        <group_list>
          <group group_id="O1">
            <title>Validation Group</title>
            <description>Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples</description>
          </group>
          <group group_id="O2">
            <title>SH#1</title>
            <description>Male patient, Total IgE: 28918 KU/L; Der p2 IgE: 64.4 KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O3">
            <title>SH#2</title>
            <description>Male patient, Total IgE: 22311 KU/L; Der p2 IgE: 91.24 KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O4">
            <title>SH#3</title>
            <description>Female patient, Total IgE: 5333 KU/L; Der p2 IgE: &gt;100 KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O5">
            <title>SH#4</title>
            <description>Male patient, Total IgE: 4070 KU/L; Der p2 IgE: &gt;100 KU/L; clinical diagnosis: Eczema, Urticaria</description>
          </group>
          <group group_id="O6">
            <title>SH#5</title>
            <description>Male patient, Total IgE: 379 KU/L; Der p2 IgE: 0.15 KU/L; clinical diagnosis: Exercise-induced anaphylaxis</description>
          </group>
          <group group_id="O7">
            <title>SH#6</title>
            <description>Female patient, Total IgE: 13 KU/L; Der p2 IgE: &lt;0.1 KU/L; clinical diagnosis: Mast cell activation syndrome</description>
          </group>
          <group group_id="O8">
            <title>SH#7</title>
            <description>Male patient, Total IgE: 67 KU/L; Der p2 IgE: None KiloUnits (KU)/L; clinical diagnosis: Urticaria</description>
          </group>
        </group_list>
        <measure>
          <title>Evaluation of Patient's Serum for Autoreactivity on Normal Average Responder Mast Cell Activation</title>
          <description>Patient's serum was incubated with mast cells derived from normal donors for detection of mast cell activation as evidenced by histamine release.</description>
          <population>Serum samples were obtained from 19 patients in total, of whom 12 were in the validation group. The other 7 patients were studied more extensively in the trial and their data is reported individually in this section and thereafter.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                    <measurement group_id="O7" value="0"/>
                    <measurement group_id="O8" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage Histamine Release by Normal Average Responder Mast Cells + Patient's Serum to Assess Autoreactivity</title>
        <description>percentage of total histamine release by normal average responder mast cells that had been activated with patient's serum</description>
        <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
        <population>Mast cells derived from the validation group is reported as a group (mean +/-SD). The other 7 allergic patients were analysed and reported individually as explained earlier.</population>
        <group_list>
          <group group_id="O1">
            <title>Validation Group</title>
            <description>Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples</description>
          </group>
          <group group_id="O2">
            <title>SH#1</title>
            <description>Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O3">
            <title>SH#2</title>
            <description>Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O4">
            <title>SH#3</title>
            <description>Female patient, Total IgE: 5333KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O5">
            <title>SH#4</title>
            <description>Male patient, Total IgE: 4070KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema, Urticaria</description>
          </group>
          <group group_id="O6">
            <title>SH#5</title>
            <description>Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis</description>
          </group>
          <group group_id="O7">
            <title>SH#6</title>
            <description>Female patient, Total IgE: 13KU/L; Der p2IgE: &lt;0.1KU/L; clinical diagnosis: Mast cell activation syndrome</description>
          </group>
          <group group_id="O8">
            <title>SH#7</title>
            <description>Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Histamine Release by Normal Average Responder Mast Cells + Patient's Serum to Assess Autoreactivity</title>
          <description>percentage of total histamine release by normal average responder mast cells that had been activated with patient's serum</description>
          <population>Mast cells derived from the validation group is reported as a group (mean +/-SD). The other 7 allergic patients were analysed and reported individually as explained earlier.</population>
          <units>percentage of histamine released</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
                <count group_id="O8" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.15" spread="0.71"/>
                    <measurement group_id="O2" value="32.1"/>
                    <measurement group_id="O3" value="3.3"/>
                    <measurement group_id="O4" value="2.8"/>
                    <measurement group_id="O5" value="3.4"/>
                    <measurement group_id="O6" value="5.1"/>
                    <measurement group_id="O7" value="3.2"/>
                    <measurement group_id="O8" value="3.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage Histamine Release by Patient's Mast Cells + Immunoglobulin E (IgE)/Anti-IgE</title>
        <description>percentage of total histamine release by patient's mast cells that had been activated with anti-IgE</description>
        <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
        <population>Mast cells derived from 7 allergic patients were analysed and reported individually. Patients in the validation group were not measured for this outcome and their samples were only used to validate the assay.</population>
        <group_list>
          <group group_id="O1">
            <title>SH#1</title>
            <description>Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O2">
            <title>SH#2</title>
            <description>Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O3">
            <title>SH#3</title>
            <description>Female patient, Total IgE: 5333KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O4">
            <title>SH#4</title>
            <description>Male patient, Total IgE: 4070KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema, Urticaria</description>
          </group>
          <group group_id="O5">
            <title>SH#5</title>
            <description>Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis</description>
          </group>
          <group group_id="O6">
            <title>SH#6</title>
            <description>Female patient, Total IgE: 13KU/L; Der p2IgE: &lt;0.1KU/L; clinical diagnosis: Mast cell activation syndrome</description>
          </group>
          <group group_id="O7">
            <title>SH#7</title>
            <description>Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage Histamine Release by Patient's Mast Cells + Immunoglobulin E (IgE)/Anti-IgE</title>
          <description>percentage of total histamine release by patient's mast cells that had been activated with anti-IgE</description>
          <population>Mast cells derived from 7 allergic patients were analysed and reported individually. Patients in the validation group were not measured for this outcome and their samples were only used to validate the assay.</population>
          <units>percentage of histamine release</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.5"/>
                    <measurement group_id="O2" value="38.3"/>
                    <measurement group_id="O3" value="69.6"/>
                    <measurement group_id="O4" value="47.9"/>
                    <measurement group_id="O5" value="36.3"/>
                    <measurement group_id="O6" value="45.5"/>
                    <measurement group_id="O7" value="41.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Histamine Release by Patient's Mast Cells + Patient's Serum + Allergen</title>
        <description>Percentage of total histamine release when patient's mast cells were activated with patient's own serum and Der p2. Each patient's results are reported individually.</description>
        <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
        <population>Mast cells derived from 7 allergic patients were analysed and reported individually. Patients in the validation group were not measured for this outcome and their samples were only used to validate the assay.</population>
        <group_list>
          <group group_id="O1">
            <title>SH#1</title>
            <description>Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O2">
            <title>SH#2</title>
            <description>Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O3">
            <title>SH#3</title>
            <description>Female patient, Total IgE: 5333KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O4">
            <title>SH#4</title>
            <description>Male patient, Total IgE: 4070KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema, Urticaria</description>
          </group>
          <group group_id="O5">
            <title>SH#5</title>
            <description>Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis</description>
          </group>
          <group group_id="O6">
            <title>SH#6</title>
            <description>Female patient, Total IgE: 13KU/L; Der p2IgE: &lt;0.1KU/L; clinical diagnosis: Mast cell activation syndrome</description>
          </group>
          <group group_id="O7">
            <title>SH#7</title>
            <description>Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Histamine Release by Patient's Mast Cells + Patient's Serum + Allergen</title>
          <description>Percentage of total histamine release when patient's mast cells were activated with patient's own serum and Der p2. Each patient's results are reported individually.</description>
          <population>Mast cells derived from 7 allergic patients were analysed and reported individually. Patients in the validation group were not measured for this outcome and their samples were only used to validate the assay.</population>
          <units>percentage of histamine release</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.5"/>
                    <measurement group_id="O2" value="54.7"/>
                    <measurement group_id="O3" value="79"/>
                    <measurement group_id="O4" value="8.4"/>
                    <measurement group_id="O5" value="0.2"/>
                    <measurement group_id="O6" value="0.2"/>
                    <measurement group_id="O7" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Cell Yield Per 100ml Blood</title>
        <description>Cell yield of patient's mast cell culture after 9 weeks in culture as an index of cell growth and differentiation.</description>
        <time_frame>Mast cells studied after 9 weeks in culture</time_frame>
        <population>Mast cells derived from 7 allergic patients were analysed and reported individually. Patients in the validation group were not measured for this outcome and their samples were only used to validate the assay.</population>
        <group_list>
          <group group_id="O1">
            <title>SH#1</title>
            <description>Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O2">
            <title>SH#2</title>
            <description>Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O3">
            <title>SH#3</title>
            <description>Female patient, Total IgE: 5333KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema</description>
          </group>
          <group group_id="O4">
            <title>SH#4</title>
            <description>Male patient, Total IgE: 4070KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema, Urticaria</description>
          </group>
          <group group_id="O5">
            <title>SH#5</title>
            <description>Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis</description>
          </group>
          <group group_id="O6">
            <title>SH#6</title>
            <description>Female patient, Total IgE: 13KU/L; Der p2IgE: &lt;0.1KU/L; clinical diagnosis: Mast cell activation syndrome</description>
          </group>
          <group group_id="O7">
            <title>SH#7</title>
            <description>Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria</description>
          </group>
        </group_list>
        <measure>
          <title>Cell Yield Per 100ml Blood</title>
          <description>Cell yield of patient's mast cell culture after 9 weeks in culture as an index of cell growth and differentiation.</description>
          <population>Mast cells derived from 7 allergic patients were analysed and reported individually. Patients in the validation group were not measured for this outcome and their samples were only used to validate the assay.</population>
          <units>Cell yield per 100ml blood</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
                <count group_id="O7" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14045000"/>
                    <measurement group_id="O2" value="2895522"/>
                    <measurement group_id="O3" value="115294"/>
                    <measurement group_id="O4" value="625263"/>
                    <measurement group_id="O5" value="4867778"/>
                    <measurement group_id="O6" value="352000"/>
                    <measurement group_id="O7" value="1400000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>18 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Validation Group</title>
          <description>Mast cell activation test employing normal donor cultured mast cells and allergic patient serum samples</description>
        </group>
        <group group_id="E2">
          <title>SH#1</title>
          <description>Male patient, Total IgE: 28918KU/L; Der p2IgE: 64.4KU/L; clinical diagnosis: Eczema</description>
        </group>
        <group group_id="E3">
          <title>SH#2</title>
          <description>Male patient, Total IgE: 22311KU/L; Der p2IgE: 91.24KU/L; clinical diagnosis: Eczema</description>
        </group>
        <group group_id="E4">
          <title>SH#3</title>
          <description>Female patient, Total IgE: 5333KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema</description>
        </group>
        <group group_id="E5">
          <title>SH#4</title>
          <description>Male patient, Total IgE: 4070KU/L; Der p2IgE: &gt;100KU/L; clinical diagnosis: Eczema, Urticaria</description>
        </group>
        <group group_id="E6">
          <title>SH#5</title>
          <description>Male patient, Total IgE: 379KU/L; Der p2IgE: 0.15KU/L; clinical diagnosis: Exercise-induced anaphylaxis</description>
        </group>
        <group group_id="E7">
          <title>SH#6</title>
          <description>Female patient, Total IgE: 13KU/L; Der p2IgE: &lt;0.1KU/L; clinical diagnosis: Mast cell activation syndrome</description>
        </group>
        <group group_id="E8">
          <title>SH#7</title>
          <description>Male patient, Total IgE: 67KU/L; Der p2IgE: None KU/L; clinical diagnosis: Urticaria</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="1"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="1"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Tak Hong Lee</name_or_title>
      <organization>Hong Kong Sanatorium &amp; Hospital</organization>
      <phone>28358430</phone>
      <email>TakHong.Lee@hksh.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

